Intermediate Capital Group plc : Q3 Trading Statement for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
32
Intermediate Capital Group plc : Q3 Trading Statement for the period to 31 December 2018

 

Highlights

  • Inflows in the third quarter were €1.9bn; of which €1.0bn has been raised across our capital markets funds and €0.5bn raised for Strategic Equity III. Year to date inflows amount to €8.0bn  
  • Total AUM 5% higher at €35.2bn and third party fee earning AUM 7% higher at €27.9bn, compared to 30 September 2018  
  • Fund deployment remains strong across strategies  
  • All funds on course to meet or exceed their return hurdle rates; recent capital markets volatility has not impacted valuations and fund performance remains strong.

Benoit Durteste, CEO, said:

“Strong investment performance, underpinned by steady demand for alternative asset classes, continues to drive positive inflows, despite the challenging macro-economic environment.

“It is pleasing to see this demand benefiting a broad range of our fund strategies – most notably in the third quarter for Strategic Equity III and our open-ended capital market funds. Our local teams continue to find attractive investment opportunities and where appropriate, they are capitalising on market liquidity to realise existing assets, lock in performance and return capital to investors.

“We continue to have confidence in our ability to grow despite geopolitical uncertainties, building our capabilities in newer asset classes to complement our more mature businesses and enhance our longer term growth prospects. We remain alert to the opportunities that any market dislocation may present to us.”

Business review

Total AUM increased 5% over the three months to 31 December 2018 to €35.2bn, including our €2.4bn balance sheet investment portfolio. We have raised over €1bn for our capital markets strategies, including a €0.5bn segregated mandate, our largest ever. This brings the total raised in the last two years for this scalable asset class to over €2.5bn (excluding CLOs).

Fundraising for Strategic Equity III is underway, targeting a fund significantly larger than its predecessor which raised $0.9bn of third party money.  Strategic Equity III raised €546m in the period and, with fees on committed capital from first close, fundraising is having an immediate positive impact on our profits. We also completed Fundraising for Europe Fund VII and saw further inflows for ICG Longbow Development Fund.

Third party AUM by strategic asset class at 31 December 2018 was as follows:

  Corporate Investments €m Capital Market Investments €m Real Asset Investments €m Secondary Investments €m Total Third Party AUM €m
At 30 September 2018 17,200   8,835 3,631   1,562 31,228  
Additions 132   1,010 118   599 1,859  
Realisations (152 ) - (162 ) - (314 )
FX and other 2   38 (18 ) 15 37  
At 31 December 2018 17,182   9,883 3,569   2,176 32,810  
Fee earning AUM - at 31 December 2018 13,059   9,883 2,927   2,012 27,881  

We have continued to source attractive investments and deployed capital in the quarter while maintaining our disciplined investment culture in a competitive investment market. The total amount of capital deployed on behalf of our direct investment funds was £880m in the quarter (three months to 31 December 2017: £1,253m). The direct investment funds are investing as follows, based on third party funds raised at 31 December 2018:

Strategic asset class Fund % invested at 31 December 2018 % invested at 30 September 2018 Assets in fund at 31 December 2018 Deals completed  in Q3
Corporate Investments ICG Europe Fund VII 30 % 28 % 4 1
Corporate Investments Senior Debt Partners III¹ 36 % 25 % 17 6
Corporate Investments Asia Pacific Fund III 93 % 91 % 8 1
Real Asset Investments ICG Longbow Real Estate Fund V 41 % 34 % 7 1
Secondary Investments Strategic Secondaries II 77 % 75 % 10 0

¹ Co-mingled fund, excluding mandates and undrawn commitments

During the quarter we have also signed, subject to completion, a pioneering transaction for our Strategic Equity funds with their first transaction in Asia. This makes our Strategic Equity business truly global and highlights its significant growth potential.

90% of our AUM is in closed end funds where outflows occur with the realisation of the underlying portfolio companies. The pace of realisations remained healthy as companies continue to take advantage of market liquidity to sell assets and lock in performance.

The balance sheet investment portfolio was £2,118m at 31 December 2018 (30 September 2018: £2,110m) with new investments offsetting the realisation of older assets. As the balance sheet solely invests to support our fund management activities, its portfolio has become increasingly diversified by geography and product with its performance reflecting that of the funds in which it invests.

The balance sheet remains well funded with available cash and unutilised bank lines of £428.4m at 31 December 2018 (30 September 2018: £390.8m) and no material refinancing requirements in the next 12 months.

Result of audit tender

As disclosed in the Group’s 2018 Annual Report and accounts, ICG must appoint a new auditor for its year ending 31 March 2021. The tender process was conducted during 2018 to allow as wide a group of participants as possible sufficient time to be able to become independent.

Following a competitive tender process led by the Audit Committee, ICG announces its intention to propose the appointment of Ernst & Young LLP as its external auditor for the financial year ending 31 March 2021. A resolution to approve their appointment will be proposed to shareholders at the Company’s AGM in July 2020.

The Board expects Deloitte LLP will remain the Group’s auditors until the year ending 31 March 2020. To facilitate an orderly transition, Ernst & Young LLP will also observe the FY20 audit.

Enquiries

Analyst / Investor enquiries:

Philip Keller, CFOO, ICG                                                                                                +44 (0) 20 3201 7700 Ian Stanlake, Investor Relations, ICG                                                                              +44 (0) 20 3201 7880

 

Media enquiries:

Alicia Wyllie, Corporate Communications, ICG                                                                +44 (0) 20 3201 7994 Neil Bennett, Sam Turvey, Maitland                                                                                +44 (0) 20 7379 5151

This trading statement has been prepared solely to provide additional information to shareholders and meets the relevant requirements of the UK Listing Authority’s Disclosure and Transparency Rules. The trading statement should not be relied on by any other party or for any other purpose.

This trading statement may contain forward looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this report and should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying such forward looking information.

These written materials are not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended, or an exemption therefrom. The issuer has not and does not intend to register any securities under the US Securities Act of 1933, as amended, and does not intend to offer any securities to the public in the United States. No money, securities or other consideration from any person inside the United States is being solicited and, if sent in response to the information contained in these written materials, will not be accepted.

This Trading Statement contains information which, prior to this announcement was inside information.

About ICG

ICG is a specialist asset manager with over 29 years’ history. We manage €35.2bn of assets in third party funds and proprietary capital, principally in closed end funds. Our strategy is to grow our specialist asset management activities to deliver increased shareholder value. Our goal is to generate income and consistently high returns whilst protecting against investment downside for our fund investors. We seek to achieve this through our expertise in investing across the capital structure. We combine flexible capital solutions, local access and insight with an entrepreneurial approach to give us a competitive edge in our markets. We operate across four asset classes - corporate, capital market, real asset and secondary investments. In addition to growing existing strategies, we are committed to innovation and pioneering new strategies across these asset classes where the market opportunity exists to deliver value to our fund investors and increase shareholder value.

We are listed on the London Stock Exchange (ticker symbol: ICP) and provide investment management and advisory services in support of our strategy and goal through a number of regulated subsidiaries, further details of which are available at: www.icgam.com .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 550

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 395

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 305

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 193

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading

Top 5 Most Recently Viewed Articles

Buena Vida y Salud ACO Celebrated for Value-Based Care Innovation

Updated Category News Views 120

Buena Vida y Salud ACO Achieves National Recognition Buena Vida y Salud ACO has garnered significant acclaim as a recipient of the prestigious 2024 NAACOS Excellence Awards. This recognition highlights the organization's successful dedication to value-based care, shaping effective healthcare solutions tailored for patient needs. Leadership and Commitment to...

Continue Reading
SSCP Lager Bidco AB Shares Insights in Quarterly Report

Updated Category News Views 162

SSCP Lager Bidco AB Shares Insights in Quarterly Report Introduction to the Interim Report SSCP Lager Bidco AB (publ) recently released an interim report detailing the developments from April 1 to June 30 of a specific year, highlighting significant milestones and financial performance. Key Highlights of the Interim Report In this latest report, SSCP Lager Bidco AB...

Continue Reading
Important Corrections to ForFarmers N.V. Shareholder Meeting

Updated Category News Views 167

Update on the Resolutions of ForFarmers N.V. Annual General Meeting In a recent communication regarding the resolutions from the Annual General Meeting of Shareholders at ForFarmers N.V., some critical information was initially misstated. This announcement focuses on clarifying these details to ensure transparency and keep our stakeholders well-informed. Corrections to...

Continue Reading
Strong Increase in U.S. House Prices Despite Rising Rates

Updated Category News Views 90

U.S. House Prices Show Remarkable Growth The latest data reveals that U.S. single-family house prices experienced a strong increase in September, presenting challenges for many potential homeowners due to rising costs. This upward trend in the housing market is noteworthy, particularly as mortgage rates have begun to climb. Monthly Price Adjustments According to the...

Continue Reading
Upbeat BidCo Increases Buyout Offer Price for Believe's Shares

Updated Category News Views 208

Upbeat BidCo Raises Its Public Buyout Offer for Believe In an exciting development for investors, Upbeat BidCo has decided to increase its public buyout offer for Believe to 17.20 euros per share. This decision reflects a commitment to maximizing shareholder value while ensuring the future growth of Believe, a prominent digital music company. Significant Premium on the...

Continue Reading